Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s stock price traded up 2% during trading on Monday . The company traded as high as GBX 8 ($0.10) and last traded at GBX 7.75 ($0.10). 250,062 shares were traded during mid-day trading, a decline of 21% from the average session volume of 317,272 shares. The stock had previously closed at GBX 7.60 ($0.10).
Ondine Biomedical Stock Performance
The business’s 50 day simple moving average is GBX 7.66 and its two-hundred day simple moving average is GBX 7.52. The firm has a market capitalization of £21.49 million, a PE ratio of -258.33 and a beta of 0.10. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37.
Ondine Biomedical Company Profile
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- How to Invest in Blue Chip Stocks
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- About the Markup Calculator
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
